<?xml version="1.0" encoding="UTF-8"?>
<rootTag>
<Award>
<AwardTitle>STTR Phase I:  Rapid Acting Disinfectant Spray for Slowing the Spread of COVID-19</AwardTitle>
<AGENCY>NSF</AGENCY>
<AwardEffectiveDate>08/01/2020</AwardEffectiveDate>
<AwardExpirationDate>01/31/2022</AwardExpirationDate>
<AwardTotalIntnAmount>255536.00</AwardTotalIntnAmount>
<AwardAmount>255536</AwardAmount>
<AwardInstrument>
<Value>Standard Grant</Value>
</AwardInstrument>
<Organization>
<Code>07070000</Code>
<Directorate>
<Abbreviation>ENG</Abbreviation>
<LongName>Directorate For Engineering</LongName>
</Directorate>
<Division>
<Abbreviation>IIP</Abbreviation>
<LongName>Div Of Industrial Innovation &amp; Partnersh</LongName>
</Division>
</Organization>
<ProgramOfficer>
<SignBlockName>Anna Brady-Estevez</SignBlockName>
<PO_EMAI>abrady@nsf.gov</PO_EMAI>
<PO_PHON>7032927077</PO_PHON>
</ProgramOfficer>
<AbstractNarration>The broader impact/commercial potential of this Small Business Technology Transfer (STTR) project is development of a disinfectant spray to curb the transmission of SARS-CoV-2 via contact with contaminated surfaces. COVID-19 transmission occurs primarily via respiratory droplets produced by an infected person and by contact with a surface where a droplet containing the virus exists. Mitigating infection by contact with surfaces is a measure that will slow the spread of novel viruses ahead of development of a vaccine or other protective measures. In conjunction with other measures, a novel disinfectant will support public health during the COVID-19 pandemic. Current disinfectants require times ranging from 30 seconds to 10 minutes for disinfection to begin after application and do not continue to disinfect. The proposed technology creates a temporary, continually disinfecting film that remains on the application surface. &lt;br/&gt;&lt;br/&gt;This STTR Phase I project will demonstrate both the rapid performance of a novel spray and its ability to form a temporary and continually disinfecting film post=application. This technology employs a select medium containing fast-response doped nanoceria where the oxidizing response/mechanism is engineered to perform several disinfectant reactions in parallel. A safe, rapid, multi-disinfectant approach using engineered nanoceria has not previously been demonstrated for use. The project will also demonstrate the post-application disinfection properties. The goals of this project will be achieved with the following: 1) development of an anti-viral, multi-mechanism disinfectant formulation, 2) demonstration of efficacy and safety, 3) study of product stability, and 4) demonstration of temporary film formation, stability, and activity.&lt;br/&gt;&lt;br/&gt;This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.</AbstractNarration>
<MinAmdLetterDate>08/10/2020</MinAmdLetterDate>
<MaxAmdLetterDate>08/10/2020</MaxAmdLetterDate>
<ARRAAmount/>
<TRAN_TYPE>Grant</TRAN_TYPE>
<CFDA_NUM>47.041</CFDA_NUM>
<NSF_PAR_USE_FLAG>1</NSF_PAR_USE_FLAG>
<FUND_AGCY_CODE>4900</FUND_AGCY_CODE>
<AWDG_AGCY_CODE>4900</AWDG_AGCY_CODE>
<AwardID>2032056</AwardID>
<Investigator>
<FirstName>Christina</FirstName>
<LastName>Drake</LastName>
<PI_MID_INIT/>
<PI_SUFX_NAME/>
<PI_FULL_NAME>Christina Drake</PI_FULL_NAME>
<EmailAddress>cdrake@kismettechnologies.com</EmailAddress>
<PI_PHON>4074134180</PI_PHON>
<NSF_ID>000803748</NSF_ID>
<StartDate>08/10/2020</StartDate>
<EndDate/>
<RoleCode>Principal Investigator</RoleCode>
</Investigator>
<Institution>
<Name>KISMET TECHNOLOGIES LLC</Name>
<CityName>WINTER PARK</CityName>
<CountyName/>
<ZipCode>327924703</ZipCode>
<PhoneNumber>4074134180</PhoneNumber>
<StreetAddress>2331 BANCHORY RD</StreetAddress>
<StreetAddress2/>
<CountryName>United States</CountryName>
<StateName>Florida</StateName>
<StateCode>FL</StateCode>
<CONGRESSDISTRICT>07</CONGRESSDISTRICT>
<CONGRESS_DISTRICT_ORG>FL07</CONGRESS_DISTRICT_ORG>
<ORG_DUNS_NUM>116952204</ORG_DUNS_NUM>
<ORG_LGL_BUS_NAME>KISMET TECHNOLOGIES LLC</ORG_LGL_BUS_NAME>
<ORG_PRNT_DUNS_NUM/>
</Institution>
<Performance_Institution>
<Name><![CDATA[KISMET TECHNOLOGIES LLC]]></Name>
<CityName>Orlando</CityName>
<CountyName/>
<StateCode>FL</StateCode>
<ZipCode>328263230</ZipCode>
<StreetAddress><![CDATA[3259 Progress Drive #175B]]></StreetAddress>
<CountryCode>US</CountryCode>
<CountryName>United States</CountryName>
<StateName>Florida</StateName>
<CountryFlag>1</CountryFlag>
<CONGRESSDISTRICT>07</CONGRESSDISTRICT>
<CONGRESS_DISTRICT_PERF>FL07</CONGRESS_DISTRICT_PERF>
</Performance_Institution>
<ProgramElement>
<Code>1505</Code>
<Text>STTR Phase I</Text>
</ProgramElement>
<ProgramReference>
<Code>096Z</Code>
<Text>COVID-19 Research</Text>
</ProgramReference>
<ProgramReference>
<Code>8030</Code>
<Text>Chemical Technology</Text>
</ProgramReference>
<Appropriation>
<Code>0120</Code>
<Name>NSF RESEARCH &amp; RELATED ACTIVIT</Name>
<APP_SYMB_ID>040100</APP_SYMB_ID>
</Appropriation>
<FUND_OBLG>2020~255536</FUND_OBLG>
</Award>
</rootTag>
